FR2873373B1 - DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION - Google Patents

DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Info

Publication number: FR2873373B1
Authority: FR; France
Prior art keywords: arylmorpholin; derivatives; preparation; therapeutic application; therapeutic
Prior art date: 2004-07-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

FR0408222A

Other languages

French (fr)

Other versions

FR2873373A1 (en

Inventor

Alt Xavier Emonds

Vincenzo Proietto

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Synthelabo SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-23

Filing date

2004-07-23

Publication date

2006-09-08

2004-07-23 Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA

2004-07-23 Priority to FR0408222A priority Critical patent/FR2873373B1/en

2005-07-19 Priority to UY29022A priority patent/UY29022A1/en

2005-07-19 Priority to PE2005000833A priority patent/PE20060553A1/en

2005-07-20 Priority to GT200500196A priority patent/GT200500196A/en

2005-07-20 Priority to AU2005276352A priority patent/AU2005276352A1/en

2005-07-20 Priority to ZA200700603A priority patent/ZA200700603B/en

2005-07-20 Priority to EA200700098A priority patent/EA011035B1/en

2005-07-20 Priority to JP2007521987A priority patent/JP4812759B2/en

2005-07-20 Priority to MYPI20053337A priority patent/MY142757A/en

2005-07-20 Priority to PCT/FR2005/001852 priority patent/WO2006021654A1/en

2005-07-20 Priority to EP05790796.6A priority patent/EP1773823B1/en

2005-07-20 Priority to HK07112751.7A priority patent/HK1107340B/en

2005-07-20 Priority to BRPI0513581-8A priority patent/BRPI0513581A/en

2005-07-20 Priority to MX2007000814A priority patent/MX2007000814A/en

2005-07-20 Priority to UAA200701878A priority patent/UA86082C2/en

2005-07-20 Priority to CA002573446A priority patent/CA2573446A1/en

2005-07-20 Priority to KR1020077001501A priority patent/KR20070034066A/en

2005-07-20 Priority to CN2005800286192A priority patent/CN101006084B/en

2005-07-21 Priority to ARP050103016A priority patent/AR050262A1/en

2005-07-21 Priority to PA20058640101A priority patent/PA8640101A1/en

2005-07-21 Priority to HN2005000380A priority patent/HN2005000380A/en

2005-07-22 Priority to TW094124977A priority patent/TW200603800A/en

2005-07-22 Priority to SV2005002176A priority patent/SV2006002176A/en

2006-01-27 Publication of FR2873373A1 publication Critical patent/FR2873373A1/en

2006-09-08 Application granted granted Critical

2006-09-08 Publication of FR2873373B1 publication Critical patent/FR2873373B1/en

2006-12-26 Priority to TNP2006000438A priority patent/TNSN06438A1/en

2007-01-01 Priority to IL180484A priority patent/IL180484A0/en

2007-01-09 Priority to US11/621,224 priority patent/US7521449B2/en

2007-01-09 Priority to CR8843A priority patent/CR8843A/en

2007-01-17 Priority to MA29619A priority patent/MA28741B1/en

2007-01-17 Priority to EC2007007181A priority patent/ECSP077181A/en

2007-02-22 Priority to NO20071020A priority patent/NO20071020L/en

2024-07-23 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FR0408222A 2004-07-23 2004-07-23 DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION Expired - Lifetime FR2873373B1 (en)

Priority Applications (30)

Application Number	Priority Date	Filing Date	Title
FR0408222A FR2873373B1 (en)	2004-07-23	2004-07-23	DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PE2005000833A PE20060553A1 (en)	2004-07-23	2005-07-19	DERIVATIVES OF 4-ARILMORFOLIN-3-ONA AS ANTAGONISTS OF THE NEUROQUININ A NK2 RECEPTOR
UY29022A UY29022A1 (en)	2004-07-23	2005-07-19	DERIVATIVES OF 4 - ARILMORFOLIN - 3 - ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.-
CN2005800286192A CN101006084B (en)	2004-07-23	2005-07-20	4-Arylmorpholin-3-one derivatives, their preparation and their therapeutic use
ZA200700603A ZA200700603B (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
EA200700098A EA011035B1 (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
JP2007521987A JP4812759B2 (en)	2004-07-23	2005-07-20	4-Arylmorpholin-3-one derivatives, their preparation and therapeutic use
MYPI20053337A MY142757A (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation thereof and therapeutic application thereof
PCT/FR2005/001852 WO2006021654A1 (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
EP05790796.6A EP1773823B1 (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
HK07112751.7A HK1107340B (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
BRPI0513581-8A BRPI0513581A (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, their preparation and their therapeutic application
MX2007000814A MX2007000814A (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof.
UAA200701878A UA86082C2 (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof
CA002573446A CA2573446A1 (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
KR1020077001501A KR20070034066A (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, their preparation and therapeutic uses
GT200500196A GT200500196A (en)	2004-07-23	2005-07-20	DERIVATIVES OF 4-ARILMORFOLIN-3-ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
AU2005276352A AU2005276352A1 (en)	2004-07-23	2005-07-20	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
ARP050103016A AR050262A1 (en)	2004-07-23	2005-07-21	DERIVATIVES OF 4- ARILMORFOLIN-3-ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPY
PA20058640101A PA8640101A1 (en)	2004-07-23	2005-07-21	DERIVATIVES OF 4-ARILMORFOLIN-3-ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
HN2005000380A HN2005000380A (en)	2004-07-23	2005-07-21	DERIVATIVES OF 4-ARILMORFOLIN-3-ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
TW094124977A TW200603800A (en)	2004-07-23	2005-07-22	4-arylmorpholin-3-one derivatives, preparation thereof and therapeutic application thereof
SV2005002176A SV2006002176A (en)	2004-07-23	2005-07-22	DERIVATIVES OF 4-ARIL MORFOLIN-3-ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
TNP2006000438A TNSN06438A1 (en)	2004-07-23	2006-12-26	DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
IL180484A IL180484A0 (en)	2004-07-23	2007-01-01	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
US11/621,224 US7521449B2 (en)	2004-07-23	2007-01-09	4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof
CR8843A CR8843A (en)	2004-07-23	2007-01-09	DERIVATIVES OF 4-ARILMORFOLIN-3-ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
EC2007007181A ECSP077181A (en)	2004-07-23	2007-01-17	DERIVATIVES OF 4-ARILMORFOLIN-3-ONA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
MA29619A MA28741B1 (en)	2004-07-23	2007-01-17	DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
NO20071020A NO20071020L (en)	2004-07-23	2007-02-22	4-arylmorpholine-3-one derivatives, preparation and therapeutic use thereof

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0408222A FR2873373B1 (en)	2004-07-23	2004-07-23	DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (2)

Publication Number	Publication Date
FR2873373A1 FR2873373A1 (en)	2006-01-27
FR2873373B1 true FR2873373B1 (en)	2006-09-08

Family

ID=34951659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0408222A Expired - Lifetime FR2873373B1 (en)	2004-07-23	2004-07-23	DERIVATIVES OF 4-ARYLMORPHOLIN-3-ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Country Status (29)

Country	Link
US (1)	US7521449B2 (en)
EP (1)	EP1773823B1 (en)
JP (1)	JP4812759B2 (en)
KR (1)	KR20070034066A (en)
CN (1)	CN101006084B (en)
AR (1)	AR050262A1 (en)
AU (1)	AU2005276352A1 (en)
BR (1)	BRPI0513581A (en)
CA (1)	CA2573446A1 (en)
CR (1)	CR8843A (en)
EA (1)	EA011035B1 (en)
EC (1)	ECSP077181A (en)
FR (1)	FR2873373B1 (en)
GT (1)	GT200500196A (en)
HN (1)	HN2005000380A (en)
IL (1)	IL180484A0 (en)
MA (1)	MA28741B1 (en)
MX (1)	MX2007000814A (en)
MY (1)	MY142757A (en)
NO (1)	NO20071020L (en)
PA (1)	PA8640101A1 (en)
PE (1)	PE20060553A1 (en)
SV (1)	SV2006002176A (en)
TN (1)	TNSN06438A1 (en)
TW (1)	TW200603800A (en)
UA (1)	UA86082C2 (en)
UY (1)	UY29022A1 (en)
WO (1)	WO2006021654A1 (en)
ZA (1)	ZA200700603B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2912058A1 (en) *	2007-02-07	2008-08-08	Sanofi Aventis Sa	Treatment or prevention of sexual dysfunction, e.g. lack of sexual desire or erectile dysfunction, uses neurokinin A NK2 receptor antagonist, e.g. sareductant
EP3160469B1 (en)	2014-06-25	2021-04-28	Emory University	Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2729954B1 (en) *	1995-01-30	1997-08-01	Sanofi Sa	SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2751654B1 (en) *	1996-07-26	1998-10-23	Sanofi Sa	SUBSTITUTED HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2738819B1 (en) *	1995-09-14	1997-12-05	Sanofi Sa	NOVEL SELECTIVE ANTAGONIST COMPOUNDS OF HUMAN NK3 RECEPTOR, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HU224225B1 (en) *	1995-12-01	2005-06-28	Sankyo Co. Ltd.	Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation, and their use for the preparation of pharmaceutical compositions
GB9601680D0 (en) *	1996-01-27	1996-03-27	Pfizer Ltd	Therapeutic agents
JPH11240880A (en) *	1997-12-04	1999-09-07	Sankyo Co Ltd	Alicyclic acylated heterocyclic derivative
CA2312770A1 (en) *	1997-12-04	1999-06-10	Takahide Nishi	Alicyclic acylated heterocyclic derivatives
GB9812037D0 (en) *	1998-06-04	1998-07-29	Pfizer Ltd	Piperidones
FR2789390B3 (en) *	1999-02-10	2001-03-09	Sanofi Sa	NOVEL PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2791346B3 (en) *	1999-03-25	2001-04-27	Sanofi Sa	NOVEL MORPHOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
KR20020067548A (en) *	1999-12-17	2002-08-22	쉐링 코포레이션	Selective neurokinin antagonists
FR2824828B1 (en) *	2001-05-21	2005-05-20	Sanofi Synthelabo	NOVEL DERIVATIVES OF PIPERIDINECARBOXAMIDE, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
GB0130261D0 (en) *	2001-12-18	2002-02-06	Pfizer Ltd	Lactams as tachykinin antagonists

2004
- 2004-07-23 FR FR0408222A patent/FR2873373B1/en not_active Expired - Lifetime
2005
- 2005-07-19 PE PE2005000833A patent/PE20060553A1/en not_active Application Discontinuation
- 2005-07-19 UY UY29022A patent/UY29022A1/en unknown
- 2005-07-20 MX MX2007000814A patent/MX2007000814A/en active IP Right Grant
- 2005-07-20 UA UAA200701878A patent/UA86082C2/en unknown
- 2005-07-20 AU AU2005276352A patent/AU2005276352A1/en not_active Abandoned
- 2005-07-20 EP EP05790796.6A patent/EP1773823B1/en not_active Expired - Lifetime
- 2005-07-20 GT GT200500196A patent/GT200500196A/en unknown
- 2005-07-20 CN CN2005800286192A patent/CN101006084B/en not_active Expired - Fee Related
- 2005-07-20 MY MYPI20053337A patent/MY142757A/en unknown
- 2005-07-20 BR BRPI0513581-8A patent/BRPI0513581A/en not_active IP Right Cessation
- 2005-07-20 JP JP2007521987A patent/JP4812759B2/en not_active Expired - Fee Related
- 2005-07-20 ZA ZA200700603A patent/ZA200700603B/en unknown
- 2005-07-20 EA EA200700098A patent/EA011035B1/en not_active IP Right Cessation
- 2005-07-20 CA CA002573446A patent/CA2573446A1/en not_active Abandoned
- 2005-07-20 KR KR1020077001501A patent/KR20070034066A/en not_active Ceased
- 2005-07-20 WO PCT/FR2005/001852 patent/WO2006021654A1/en not_active Ceased
- 2005-07-21 PA PA20058640101A patent/PA8640101A1/en unknown
- 2005-07-21 AR ARP050103016A patent/AR050262A1/en unknown
- 2005-07-21 HN HN2005000380A patent/HN2005000380A/en unknown
- 2005-07-22 SV SV2005002176A patent/SV2006002176A/en not_active Application Discontinuation
- 2005-07-22 TW TW094124977A patent/TW200603800A/en unknown
2006
- 2006-12-26 TN TNP2006000438A patent/TNSN06438A1/en unknown
2007
- 2007-01-01 IL IL180484A patent/IL180484A0/en unknown
- 2007-01-09 US US11/621,224 patent/US7521449B2/en not_active Expired - Fee Related
- 2007-01-09 CR CR8843A patent/CR8843A/en unknown
- 2007-01-17 MA MA29619A patent/MA28741B1/en unknown
- 2007-01-17 EC EC2007007181A patent/ECSP077181A/en unknown
- 2007-02-22 NO NO20071020A patent/NO20071020L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
ECSP077181A (en)	2007-02-28
UA86082C2 (en)	2009-03-25
WO2006021654A1 (en)	2006-03-02
AU2005276352A1 (en)	2006-03-02
TW200603800A (en)	2006-02-01
HK1107340A1 (en)	2008-04-03
FR2873373A1 (en)	2006-01-27
TNSN06438A1 (en)	2008-02-22
EA011035B1 (en)	2008-12-30
MX2007000814A (en)	2007-04-02
GT200500196A (en)	2006-03-02
WO2006021654A8 (en)	2007-05-24
PE20060553A1 (en)	2006-07-04
JP4812759B2 (en)	2011-11-09
IL180484A0 (en)	2007-06-03
PA8640101A1 (en)	2006-03-24
EA200700098A1 (en)	2007-06-29
EP1773823B1 (en)	2013-08-21
KR20070034066A (en)	2007-03-27
AR050262A1 (en)	2006-10-11
MY142757A (en)	2010-12-31
CR8843A (en)	2007-08-28
CA2573446A1 (en)	2006-03-02
EP1773823A1 (en)	2007-04-18
BRPI0513581A (en)	2008-05-13
HN2005000380A (en)	2009-05-14
US7521449B2 (en)	2009-04-21
CN101006084A (en)	2007-07-25
NO20071020L (en)	2007-02-22
SV2006002176A (en)	2006-01-13
UY29022A1 (en)	2006-02-24
CN101006084B (en)	2010-09-08
MA28741B1 (en)	2007-07-02
JP2008507497A (en)	2008-03-13
US20070142349A1 (en)	2007-06-21
ZA200700603B (en)	2008-10-29

Publication	Publication Date	Title
FR2868780B1 (en)	2008-10-17	DERIVATIVES OF 1-AMINO-PHTHALAZINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2872813B1 (en)	2007-01-19	2-CARBAMID-4-PHENYLTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
MA29017B1 (en)	2007-11-01	2-AMIDO-4-PHENYLTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2854158B1 (en)	2006-11-17	2-ACYLAMINO-4-PHENYLETHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2864080B1 (en)	2006-02-03	1-PIPERAZINE-AND-1-HOMOPIPERAZINE-CARBOXYLATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2854633B1 (en)	2005-06-24	PIPERIDINYL-AND PIPERAZINYL-ALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2906250B1 (en)	2008-10-31	DERIVATIVES OF 2-ARYL-6PHENYL-IMIDAZO (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2866888B1 (en)	2006-05-05	ALKYLPIPERAZINE- AND ALKYLHOMOPIPERAZINE-CARBOXYLATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2873691B1 (en)	2006-10-06	AMINO-PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2843964B1 (en)	2004-10-01	DIOXANE-2-ALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2882054B1 (en)	2007-04-13	1,5-DIARYLPYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2903985B1 (en)	2008-09-05	N- (AMINO-HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2856684B1 (en)	2008-04-11	DIPHENYLPYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2866885B1 (en)	2007-08-31	PIPERIDINYLALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2865205B1 (en)	2006-02-24	ARYLOXYALKYLCARBAMATE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
MA27233A1 (en)	2005-02-01	PIPERAZINYLACYLPIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2891828B1 (en)	2007-12-21	DERIVATIVES OF SUBSTITUTED 1-AMINO-PHTALAZINE, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2888847B1 (en)	2007-08-31	N- (HETERIARYL) -1-HETEORARYLALKYL-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION
FR2873690B1 (en)	2006-10-13	OXOPIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2880625B1 (en)	2007-03-09	N- (HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
MA29016B1 (en)	2007-11-01	PYRIDINE DERIVATIVES, THEIR PREPARATION, THEIR THERAPEUTIC APPLICATION
FR2899586B1 (en)	2008-06-20	DIMERS OF ARTEMISININE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2874015B1 (en)	2006-09-15	N- (1H-INDOLYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2860792B1 (en)	2006-02-24	THIOPHENE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2888848B1 (en)	2007-09-28	N- (ARYLALKYL) -1H-PYRRROLOPYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Legal Events

Date	Code	Title	Description
2007-02-09	CD	Change of name or company name
2016-06-13	PLFP	Fee payment	Year of fee payment: 13
2017-06-13	PLFP	Fee payment	Year of fee payment: 14